Abbvie Inc 4AB インサイダー取引

Abbvie Inc (4AB) インサイダー取引

フィルター:

日付	保有者名	取引株数	金額レンジ ($)	取引種別	価格レンジ ($)	届出終了時の株数	% 変化
2026-02-27	Mr. David Ryan PurdueSenior VP & Corporate Controller	-2.11k	489.22k	Sale to Issuer	232.08	9.01k	-18.96%
2026-03-04	Mr. David Ryan PurdueSenior VP & Corporate Controller	-5.23k	1.22M	売り	233.56	3.78k	-58.04%
2026-02-27	Mr. Demetris D. CrumExec. VP & Chief HR Officer	-1.59k	369.94k	Sale to Issuer	232.08	7.91k	-16.76%
2026-02-27	Dr. Roopal B. ThakkarExec. VP of Research & Development and Chief Scientific Officer	-8.04k	1.87M	Sale to Issuer	232.08	55.37k	-12.67%
2026-02-27	Mr. Robert A. MichaelCEO & Chairman of the Board	-36.52k	8.48M	Sale to Issuer	232.08	178.74k	-16.97%
2026-03-02	Mr. Perry C. SiatisExec. VP, General Counsel & Secretary	-18.67k	4.38M	売り	233.51 - 235.26	4.62k	-80.16%
2026-02-27	Mr. Perry C. SiatisExec. VP, General Counsel & Secretary	-14.85k	3.45M	Sale to Issuer	232.08	4.62k	-76.28%
2026-02-27	Dr. Azita Saleki-GerhardtExec. VP & COO	-16.31k	3.78M	Sale to Issuer	232.08	204.37k	-7.39%
2026-02-27	Mr. Jeffrey Ryan StewartExec. VP & Chief Commercial Officer	-23.81k	5.53M	Sale to Issuer	232.08	84.51k	-21.98%
2026-02-27	Dr. Nicholas J. DonoghoeExec. VP and Chief Business & Strategy Officer	-12.87k	2.99M	Sale to Issuer	232.08	74.43k	-14.75%
2026-02-27	Mr. Scott T. ReentsExec. VP & CFO	-21.64k	5.02M	Sale to Issuer	232.08	38.78k	-35.82%
2026-02-25	Mr. Perry C. SiatisExec. VP, General Counsel & Secretary	-22.38k	1.28M	Derivative Exercise and Sale	149.62 - 230.00	4.62k	-
2025-08-12	Dr. Azita Saleki-GerhardtExec. VP & COO	-42.37k	6.08M	Derivative Exercise and Sale	54.86 - 198.42	183.81k	-
2025-08-05	Dr. Nicholas J. DonoghoeExec. VP and Chief Business & Strategy Officer	-13.30k	2.64M	売り	198.27 - 198.59	58.25k	-18.58%